Minute Insight: Illumina Is Doing Stuff Again – More Leadership Changes
Executive Summary
The sequencing technology company, led by an interim CEO, is further shuffling its leadership following the announcement of disappointing mid-year results.
You may also be interested in...
Spinning Around – One Company's Bid To Diagnostic-ify The Metabolism
Lifespin is working on tools to characterize a patient’s metabolism and provide more detailed information about a disease.
PacBio Scores Hat Trick Of Big News To Start August
A jump in earnings, the acquisition of Apton and the launch of the long-awaited Onso sequencing system – all in one week at Pacific Biosciences.
More Kerfuffle At Illumina. This Time, It Is Job Cuts
The company is shrinking its work force and real estate footprint in a bid to save money.